PD-1 inhibition plus platinum-based chemotherapy (PBC) or PBC alone in the first-line treatment of locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma

PD-1 inhibition plus platinum-based chemotherapy (PBC) or PBC alone in the first-line treatment of locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma

BackgroundPulmonary lymphoepithelioma-like carcinoma (PLELC) is a distinctive subtype of non-small cell lung carcinoma that was not well presented in clinical studies. The management of advanced PLELC remains an important, unmet need due to the paucity of high-grade evidence. Herein, we carried out...

Full description

Bibliographic Details
Main Authors: Xuanye Zhang, Yixin Zhou, Hualin Chen, Chen Chen, Zuan Lin, Li-na He, Wei Du, Tao Chen, Shaodong Hong, Sha Fu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Immunology
Subjects:
pulmonary lymphoepithelioma-like carcinoma
PD-1
PD-L1
immunotherapy
chemotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1015444/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1015444/full

Similar Items